Log In
BCIQ
Print this Print this
 

GlucaGen

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionRecombinant glucagon for injection
Molecular Target Glucagon receptor (GCGR)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat severe hypoglycemia in diabetic patients being treated with insulin
Regulatory Designation
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today